What we do
Institutional investors
Equity products
AI Co-Investment Facility
Cleantech Co-Investment Facility
Impact investing at the EIF
Climate & Infrastructure Funds
Technology Transfer
European Angels Fund (EAF) - Co-investments with Business Angels
Venture capital
The Social Impact Accelerator (SIA)
Lower mid-market
Mezzanine Facility for Growth
EFSI Equity instrument
Single EU Equity Financial Instrument
COSME - Equity Facility for Growth
InnovFin Equity
Private equity secondary market transactions
EIF-NPI Equity Platform
ESCALAR Programme
Debt products
New ESIF ERDF Guarantee Fund initiative in Greece
EFSI Private Credit Programme
AGRI Guarantee Facility
AGRI Italy Platform Uncapped Guarantee Instrument
Credit enhancement
Cultural and Creative Sectors Guarantee Facility (CCS GF)
ENSI - Securitisation Initiative
Erasmus+ Master Loan Guarantee Facility
Skills & Education Guarantee Pilot
EREM debt products
Single EU Debt Financial Instrument
Documentary Finance Facility – Bulgaria
The SME Initiative
The SME Initiative Bulgaria
The SME Initiative Finland
The SME Initiative Italy
The SME Initiative Malta
The SME Initiative Romania
The SME Initiative Spain
Inclusive finance
EaSI Financial Instruments
EaSI Capacity Building Investments Window
EaSI Guarantee Instrument
EaSI Funded Instrument
European Progress Microfinance Facility
Entrepreneurs supported through Progress Microfinance
European Fund for Strategic Investments (EFSI)
How does EIF contribute to EFSI
How to apply for EFSI financing
Regional Development - Country and sector-specific initiatives
Normandie Garantie Agri
FAIRE - La Réunion
Auvergne Rhône-Alpes FEADER
Recovery Equity Fund of Funds of Bulgaria
Fons d’Inversió en Tecnologia Avançada (FITA) Catalonia
Dutch Future Fund (DFF)
Dutch Alternative Credit Instrument (DACI)
PORTUGAL BLUE: a new initiative for blue economy investments
JEREMIE Greece Reflows – Business Angels’ Co-Investment Equity Instrument
German Corona Matching Facility (CMF)
Portugal Growth programme
Central and Eastern European Technology Transfer (CEETT)
Croatian Growth Investment Programme (CROGIP) II
Croatian Growth Investment Programme (CROGIP)
Croatian Venture Capital Initiative 2 (CVCi 2)
AGRI Italy Platform Uncapped Guarantee Instrument
ALTER’NA – ESIF EARFD Nouvelle-Aquitaine
Baltic Innovation Fund 1 (BIF 1)
Baltic Innovation Fund 2 (BIF 2)
Central Europe Fund of Funds (CEFoF)
Croatian Venture Capital Initiative (CVCi FoF)
Competitiveness Fund-of-Funds for SMEs in Romania
The Cyprus Entrepreneurship Fund (CYPEF)
Deep and Comprehensive Free Trade Area Initiative East Guarantee Facility (DCFTA)
EU4Business Capped Guarantee
Dutch Growth Co-Investment Programme
Dutch Venture Initiative (DVI-II)
ESIF Fund-of-Funds Greece
EAFRD FoF Portugal
EAFRD FoF Romania
The ERP-EIF Facility
ERP-EIF Co-Investment Growth Facility
The LfA-EIF Facilities
The German Future Fund (GFF) - EIF Growth Facility
INAF – French National Agricultural Initiative
ESIF Energy Efficiency and Renewable Energy Malta
Regional Fund-of-Funds Romania
ESIF Fund-of-Funds Czech Republic
The Silesia EIF Fund of Funds
La Financière Région Réunion
The EIB Group Risk Enhancement Mandate (EREM)
Call for Expression of Interest for FOSTER II
Greater Anatolia Guarantee Facility (GAGF)
G43 - Anatolian Venture Capital Fund Project
InvestBG Equity Instrument
Romania Recovery Equity Fund of Funds
JEREMIE Romania Reflows – Equity Instrument
Luxembourg Future Fund 1 (LFF)
Luxembourg Future Fund 2
Mezzanine 'Fund of Fund' for Germany (MDD)
NEOTEC resources
Polish Growth Fund of Funds (PGFF)
Portugal Venture Capital Initiative (PVCi)
Scottish-European Growth Co-Investment Programme
Slovene Equity Growth Investment Programme (SEGIP)
Swedish Venture Initiative (SVI)
Turkish Growth and Innovation Fund (TGIF)
Western Balkans Enterprise Development & Innovation Facility (WB EDIF)
EAFRD FoF Greece
Irish Innovation Seed Fund (IISF)
RRF Czech Republic Fund of Funds

NeuroNation: brain fitness


Today, nearly 50 million people worldwide have Alzheimer’s disease. With ageing populations, both the number of affected patients and the associated financial costs are on the rise.

”My grandfather had Alzheimer’s, my dad is showing early signs of it and there is a high chance that I will also develop it one day,” says Jakob Futorjanski, co-founder of NeuroNation, a company based in Berlin that develops cognitive training programmes to tackle brain degeneration. “There are genetic factors we can’t change but there are also modifiable ones that we can work with to improve quality of life in later years. At the end of the day this is what matters most.”

Jakob has been working on a solution since 2011 to help users maintain and regain a healthy brain. Together with co-founder Rojahn Ahmadi, they designed a cognitive training programme that helps improve memory and attention span, thought speed and overall cognitive fitness. “Our brain is almost like a muscle: we have to stimulate it just as we do other muscles in our body,” he says.

First used as prevention for memory loss and lack of concentration in healthy adults, NeuroNation soon became a go-to programme to help rehabilitate patients suffering from the effects of stroke, brain injury, infections like sepsis, and from age-related brain degeneration  illnesses (e.g. Morbus Parkinson).

“In Germany alone, there are about 400 000 people affected by brain-related illnesses like stroke. Cognitive training therapies are vital for recovery, but waiting times can be up to 20 weeks or more, and caring for these patients with brain injuries and dementia is very costly. Digitalisation can definitely help,” Jakob explains. NeuroNation’s programme is delivered digitally and provides cognitive profile testing training of core brain functions. It algorithmically creates 100% personalised training for the user, including daily challenges “and games to make it fun. But the real beauty is that it can be done remotely from the comfort of the patient’s home and own device.”

NeuroNation received an investment from Impact Partners, a venture capital fund backed by the EIF that helped them finance the clinical validation of the application while also setting up a partnership that amplified social impact. “They helped us steer the company in the right direction,” Jakob says. “…establishing social impact performance indicators, like monitoring how many people got better through our programme. I can tell you that a total of 68 000 users have trained their brains for 10 hours or more using Neuronation upon recommendation from a healthcare professional – or 28 000 in 2020 alone.”

“Cognitive Impairment is one of the biggest issues we have in our society right now. Post-COVID-19 related cognitive impairments accelerate this development and we want to do our part. Cognitive training can help here. It’s about supporting people to regain a life worth living,” he concludes. With 20 million users worldwide, NeuroNation is definitely doing its part.

Company: NeuroNation (Germany)

Type of business: ICT; health technology, medical devices; social enterprise

Financial intermediary: Impact Partners

EIF financing: EFSI Sub-window 1; SIA

For further information about EIF intermediaries in Germany, please refer to: http://www.eif.org/what_we_do/where/de/index.htm

Note: Following the recent withdrawal of the United Kingdom from the European Union, we are updating the relevant EIF.org pages.


Copyright ©

 European Investment Fund   – The European Investment Fund is not responsible for the content of external internet sites.